Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid cancer.

O Gimm1

  • 1Department of General Surgery, Martin-Luther-University Halle-Wittenberg, Halle, Germany. oliver.gimm@medizin.uni-halle.de

Cancer Letters
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Understanding thyroid cancer genetics, including mutations in Ras, RET, and p53, is key for early diagnosis and targeted therapies. Radiation exposure is a known risk factor for papillary thyroid carcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual energy 4D-CT of parathyroid adenomas not clearly localized by sestamibi scintigraphy and ultrasonography - a retrospective study.

European journal of radiology·2020
Same author

Management of incidental gallbladder cancer in a national cohort.

The British journal of surgery·2019
Same author

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma.

Journal of internal medicine·2018
Same author

Extent of surgery for phaeochromocytomas in the genomic era.

The British journal of surgery·2018
Same author

The Transcriptional Regulation of FOXO Genes in Thyrocytes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2016
Same author

Absence of the BRAF V600E mutation in pheochromocytoma.

Journal of endocrinological investigation·2015
Same journal

RETRACTED: Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.

Cancer letters·2026
Same journal

FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic Cholangiocarcinoma.

Cancer letters·2026
Same journal

Dissection of spatial hypoxic and inflammatory ecosystem in glioblastoma.

Cancer letters·2026
Same journal

An IL-15 fusion with albumin-binding domain boosts Immunotherapy therapy in glioblastoma via FGF-2 competition regulating FGFR1/2.

Cancer letters·2026
Same journal

Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance.

Cancer letters·2026
Same journal

Aldo-keto Reductase Family 1 Member C3 Suppresses Glioma Progression via Inhibiting Prostaglandin D2-Dependent RhoA/ROCK Signaling.

Cancer letters·2026
See all related articles

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Thyroid cancer encompasses several types, ranging from benign papillary thyroid carcinoma (PTC) to aggressive undifferentiated thyroid carcinoma (UTC).
  • Genetic mutations and environmental factors like radiation play significant roles in thyroid cancer development and progression.

Purpose of the Study:

  • To review the genetic landscape of thyroid carcinoma.
  • To highlight the roles of specific genes and mutations in different thyroid cancer subtypes.
  • To discuss current treatment strategies and future therapeutic directions based on genetic insights.

Main Methods:

  • Review of existing literature on thyroid cancer genetics.
  • Analysis of gene mutations (Ras, RET, TRK, p53, PTEN) and their association with thyroid cancer types.

Related Experiment Videos

  • Examination of the role of radiation as an etiological factor.

    • Main Results:

    • Somatic Ras mutations are early events in follicular thyroid carcinomas.
    • RET and TRK rearrangements are common in papillary thyroid carcinoma (PTC).
    • Germline RET mutations cause hereditary medullary thyroid carcinoma (MTC); somatic RET mutations in sporadic MTC require further study.
    • p53 is implicated in thyroid cancer dedifferentiation, while PTEN's role needs clarification.
    • Radiation is a significant risk factor, particularly for PTC, and can induce RET rearrangements.

    Conclusions:

    • Early diagnosis and surgical intervention are crucial for thyroid cancer management.
    • While current treatments can control local disease, options for metastatic MTC and UTC are limited.
    • Advances in understanding thyroid cancer oncogenesis offer promise for developing novel, effective gene-targeted therapies.